bcr_patient_uuid	bcr_patient_barcode	form_completion_date	prospective_collection	retrospective_collection	gender	height_cm_at_diagnosis	weight_kg_at_diagnosis	race	ethnicity	history_other_malignancy	history_neoadjuvant_treatment	tumor_status	vital_status	family_history_cancer_indicator	family_history_cancer_number_relatives	history_hepato_carcinoma_risk_factors	other_hepato_carcinoma_risk_factors	viral_hepatitis_serology	radiation_treatment_adjuvant	pharmaceutical_tx_adjuvant	ablation_embolization_tx_adjuvant	histologic_diagnosis	definitive_surgical_procedure	tumor_grade	residual_tumor	ajcc_staging_edition	ajcc_tumor_pathologic_pt	ajcc_nodes_pathologic_pn	ajcc_metastasis_pathologic_pm	ajcc_pathologic_tumor_stage	vascular_invasion	child_pugh_classification	alpha_fetoprotien_at_procurement	alpha_fetoprotien_norm_range_lower	alpha_fetoprotien_norm_range_upper	platelet_count_preresection	platelet_norm_range_lower	platelet_norm_range_upper	prothrombin_time_INR_at_procurement	prothrom_time_INR_norm_range_lower	prothrombin_time_norm_range_upper	serum_albumin_preresection	serum_albumin_norm_range_lower	serum_albumin_norm_range_upper	bilirubin_total_norm_range_upper	bilirubin_total_norm_range_lower	bilirubin_total	creatinine_level_preresection	creatinine_norm_range_lower	creatinine_norm_range_upper	ishak_fibrosis_score	hepatic_inflammation_adj_tissue	ecog_score	new_tumor_event_dx_indicator	age_at_diagnosis	birth_days_to	clinical_M	clinical_N	clinical_T	clinical_stage	days_to_initial_pathologic_diagnosis	death_days_to	disease_code	extranodal_involvement	icd_10	icd_o_3_histology	icd_o_3_site	informed_consent_verified	last_contact_days_to	patient_id	project_code	stage_other	tissue_source_site	tumor_tissue_site	year_of_initial_pathologic_diagnosis
bcr_patient_uuid	bcr_patient_barcode	form_completion_date	tissue_prospective_collection_indicator	tissue_retrospective_collection_indicator	gender	height	weight	race	ethnicity	other_dx	history_of_neoadjuvant_treatment	person_neoplasm_cancer_status	vital_status	relative_family_cancer_history	cancer_first_degree_relative	hist_hepato_carc_fact	hist_hepato_carcinoma_risk	viral_hepatitis_serology	radiation_therapy	postoperative_rx_tx	post_op_ablation_embolization_tx	histological_type	specimen_collection_method_name	neoplasm_histologic_grade	residual_tumor	system_version	pathologic_T	pathologic_N	pathologic_M	pathologic_stage	vascular_tumor_cell_type	child_pugh_classification_grade	fetoprotein_outcome_value	fetoprotein_outcome_lower_limit	fetoprotein_outcome_upper_limit	platelet_result_count	platelet_result_lower_limit	platelet_result_upper_limit	prothrombin_time_result_value	inter_norm_ratio_lower_limit	intern_norm_ratio_upper_limit	albumin_result_specified_value	albumin_result_lower_limit	albumin_result_upper_limit	total_bilirubin_upper_limit	bilirubin_lower_limit	bilirubin_upper_limit	creatinine_value_in_mg_dl	creatinine_lower_level	creatinine_upper_limit	fibrosis_ishak_score	adjacent_hepatic_tissue_inflammation_extent_type	eastern_cancer_oncology_group	new_tumor_event_after_initial_treatment	age_at_initial_pathologic_diagnosis	days_to_birth	clinical_M	clinical_N	clinical_T	clinical_stage	days_to_initial_pathologic_diagnosis	days_to_death	disease_code	extranodal_involvement	icd_10	icd_o_3_histology	icd_o_3_site	informed_consent_verified	days_to_last_followup	patient_id	project_code	stage_other	tissue_source_site	tumor_tissue_site	year_of_initial_pathologic_diagnosis
CDE_ID:	CDE_ID:2673794	CDE_ID:	CDE_ID:3088492	CDE_ID:3088528	CDE_ID:2200604	CDE_ID:649	CDE_ID:651	CDE_ID:2192199	CDE_ID:2192217	CDE_ID:3382736	CDE_ID:3382737	CDE_ID:2759550	CDE_ID:5	CDE_ID:2691192	CDE_ID:3171640	CDE_ID:3171846	CDE_ID:3171859	CDE_ID:4395982	CDE_ID:2005312	CDE_ID:3397567	CDE_ID:3172120	CDE_ID:3081934	CDE_ID:3131309	CDE_ID:2785839	CDE_ID:2608702	CDE_ID:2722309	CDE_ID:3045435	CDE_ID:3203106	CDE_ID:3045439	CDE_ID:3203222	CDE_ID:3168001	CDE_ID:2931791	CDE_ID:2932074	CDE_ID:3171861	CDE_ID:2932064	CDE_ID:58304	CDE_ID:2003885	CDE_ID:2596499	CDE_ID:2459694	CDE_ID:2799755	CDE_ID:3171875	CDE_ID:58274	CDE_ID:2004085	CDE_ID:2004086	CDE_ID:2004060	CDE_ID:2718241	CDE_ID:2003891	CDE_ID:2655822	CDE_ID:2634934	CDE_ID:2183392	CDE_ID:3182621	CDE_ID:3173974	CDE_ID:88	CDE_ID:3121376	CDE_ID:2006657	CDE_ID:3008233	CDE_ID:3440331	CDE_ID:3440330	CDE_ID:3440328	CDE_ID:3440332	CDE_ID:3131740	CDE_ID:3165475	CDE_ID:	CDE_ID:3364582	CDE_ID:3226287	CDE_ID:3226275	CDE_ID:3226281	CDE_ID:3288361	CDE_ID:3008273	CDE_ID:	CDE_ID:	CDE_ID:2007104	CDE_ID:	CDE_ID:3427536	CDE_ID:2896960
00f209c3-041a-4c6e-8b0f-6383eb3c85fc	TCGA-BC-4073	2010-12-20	NO	YES	MALE	[Not Available]	[Not Available]	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	Alive	YES	3	Hemochromatosis	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Segmentectomy, Multiple	G3	R1	6th	T3	N0	MX	Stage IIIA	Macro	[Not Available]	[Not Available]	[Not Available]	[Not Available]	253	150	440	1.0	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	1.2	0.0	0.7	1.5	0.7	1.3	[Not Available]	[Not Available]	0	[Not Available]	73	-26795	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	[Not Applicable]	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	352	4073	[Not Available]	[Not Available]	BC	Liver	2009
39baf24a-4032-4c23-b3fe-2c50df1881f6	TCGA-BC-A10W	2011-3-31	NO	YES	MALE	[Not Available]	71	ASIAN	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	Dead	YES	1	Hepatitis B	[Not Available]	Hepatitis B Surface Antigen	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Lobectomy	G3	R1	5th	T4	NX	MX	[Not Available]	[Not Available]	[Not Available]	79	[Not Available]	[Not Available]	401	150	440	0.9	[Not Available]	[Not Available]	2.8	3.5	5.0	1.2	0.0	1.4	0.8	0.8	1.4	[Not Available]	[Not Available]	[Not Available]	[Not Available]	50	-18562	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	91	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	[Not Available]	A10W	[Not Available]	[Not Available]	BC	Liver	2002
3dc48ea9-a3c6-437f-af5a-88feb300cc5f	TCGA-BC-A10X	2011-3-31	NO	YES	FEMALE	[Not Available]	65	WHITE	NOT HISPANIC OR LATINO	No	No	TUMOR FREE	Dead	YES	2	No History of Primary Risk Factors	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Lobectomy	G2	R0	5th	T3a	N0	MX	Stage IIIA	Micro	[Not Available]	264	[Not Available]	[Not Available]	602	150	440	1.0	[Not Available]	[Not Available]	3.6	3.5	5.0	1.2	0.0	0.3	0.7	0.7	1.1	[Not Available]	None	[Not Available]	[Not Available]	52	-19140	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	770	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	[Not Available]	A10X	[Not Available]	[Not Available]	BC	Liver	2002
6533648f-1353-4253-b65b-d472aacf5751	TCGA-BC-A10Y	2011-3-31	NO	YES	MALE	175	77	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	Dead	NO	[Not Available]	Alcohol consumption	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Lobectomy	G3	R0	5th	T4	NX	MX	[Not Available]	Micro	[Not Available]	10575	0	10	239	150	440	1.0	[Not Available]	[Not Available]	4.0	3.5	5.0	1.2	0.0	0.5	1.0	0.9	1.4	[Not Available]	None	[Not Available]	[Not Available]	76	-28049	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	711	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	[Not Available]	A10Y	[Not Available]	[Not Available]	BC	Liver	2002
709f1e4d-f5e8-4a0b-8254-23f037f4bae7	TCGA-BC-A10Z	2011-4-1	NO	YES	FEMALE	[Not Available]	79	WHITE	NOT HISPANIC OR LATINO	No	No	TUMOR FREE	Dead	YES	1	No History of Primary Risk Factors	[Not Available]	[Unknown]	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Extended Lobectomy	G2	R0	6th	T1	N0	MX	Stage I	None	[Not Available]	779	0	10	260	150	440	0.9	[Not Available]	[Not Available]	3.1	3.5	5.0	1.2	0.0	0.6	1.2	0.7	1.1	[Not Available]	None	[Not Available]	[Not Available]	62	-22913	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	34	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	[Not Available]	A10Z	[Not Available]	[Not Available]	BC	Liver	2003
cf028bce-d20d-42b8-8507-1ec94a391e85	TCGA-BC-A110	2011-4-1	NO	YES	FEMALE	155	91	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Yes	No	WITH TUMOR	Dead	YES	2	Alcohol consumption	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Segmentectomy, Single	G1	R0	6th	T1	NX	MX	[Not Available]	None	[Not Available]	[Not Available]	0	10	288	150	440	0.9	[Not Available]	[Not Available]	3.7	3.5	5.0	1.2	0.0	0.3	3.5	0.7	1.1	[Not Available]	[Not Available]	[Not Available]	[Not Available]	51	-18951	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	2116	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	[Not Available]	A110	[Not Available]	[Not Available]	BC	Liver	2003
a2c17e87-d8bc-4160-88ae-e3e894d013e4	TCGA-BC-A112	2011-4-1	NO	YES	MALE	165	97	WHITE	NOT HISPANIC OR LATINO	Yes	No	TUMOR FREE	Dead	NO	[Not Available]	Alcohol consumption	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Segmentectomy, Multiple	G2	R0	6th	T3	NX	MX	[Not Available]	None	[Not Available]	233	0	10	218	150	440	1.1	[Not Available]	[Not Available]	4.1	3.5	5.0	1.2	0.0	0.3	2.1	0.7	1.3	0 - No Fibrosis	[Not Available]	[Not Available]	[Not Available]	80	-29511	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	153	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	[Not Available]	A112	[Not Available]	[Not Available]	BC	Liver	2009
4bbdbe77-f3cb-4b64-9826-72debb734784	TCGA-BC-A216	2011-7-8	NO	YES	FEMALE	164	151	WHITE	[Not Available]	No	No	TUMOR FREE	Alive	YES	2	No History of Primary Risk Factors	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Extended Lobectomy	G2	R0	6th	T3	NX	M0	Stage IIIA	None	[Not Available]	831	0	8	211000	140000	440000	1.4	[Not Available]	[Not Available]	3.4	3.5	5.0	1.5	0.0	0.6	0.9	0.5	1.5	0 - No Fibrosis	Mild	[Not Available]	[Not Available]	62	-22968	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	[Not Applicable]	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	1144	A216	[Not Available]	[Not Available]	BC	Liver	2008
6dcfc418-ab28-4365-95ea-c1ae254f2341	TCGA-BC-A217	2011-7-8	YES	NO	FEMALE	163	81	WHITE	[Not Available]	No	No	TUMOR FREE	Alive	NO	[Not Available]	Alcohol consumption	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	[Not Available]	G3	R0	7th	T2	NX	M0	Stage II	Micro	[Not Available]	28	0	10	243000	150000	440000	1.0	[Not Available]	[Not Available]	4.4	3.5	5.0	1.2	0.0	0.2	0.8	0.6	1.0	0 - No Fibrosis	None	[Not Available]	[Not Available]	75	-27411	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	[Not Applicable]	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	421	A217	[Not Available]	[Not Available]	BC	Liver	2010
07DD49FC-8A76-41E8-9EB3-107336F68701	TCGA-BC-A3KF	2012-4-19	YES	NO	FEMALE	173	58	WHITE	[Not Available]	No	No	TUMOR FREE	Alive	YES	2	No History of Primary Risk Factors	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Segmentectomy, Single	G2	R0	7th	T1	NX	M0	Stage I	None	[Not Available]	[Not Available]	[Not Available]	[Not Available]	171000	150000	440000	1.0	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	0.8	0.6	1.0	[Not Available]	[Not Available]	[Not Available]	[Not Available]	66	-24328	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	[Not Applicable]	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	8	A3KF	[Not Available]	[Not Available]	BC	Liver	2011
75F43FCA-200A-48B0-BB67-0693D7B91119	TCGA-BC-A3KG	2012-4-19	YES	NO	FEMALE	159	64	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	Alive	NO	[Not Available]	Alcohol consumption	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Lobectomy	G3	R0	7th	T2	N0	M0	Stage II	Micro	[Not Available]	618	0	10	499000	150000	440000	1.1	[Not Available]	[Not Available]	3.6	3.5	5.0	1.2	0.0	0.5	0.7	0.6	1.0	[Not Available]	[Not Available]	[Not Available]	[Not Available]	68	-25061	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	[Not Applicable]	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	252	A3KG	[Not Available]	[Not Available]	BC	Liver	2011
6BB5D506-8FCA-43F3-90A6-03C915D7EDE2	TCGA-BC-A5W4	2013-5-20	YES	NO	MALE	183	106	WHITE	NOT HISPANIC OR LATINO	Yes	No	TUMOR FREE	Alive	NO	[Not Available]	Alcohol consumption	[Not Available]	[Not Available]	NO	NO	NO	Hepatocellular Carcinoma	Segmentectomy, Multiple	G3	R1	7th	T3a	NX	M0	Stage IIIA	Micro	A	[Not Available]	[Not Available]	[Not Available]	102000	150000	440000	12.9	9.9	13.0	4.2	3.5	5.0	1.2	0.0	0.6	[Not Available]	0.70	1.30	[Not Available]	None	[Unknown]	NO	69	-25503	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	[Not Applicable]	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	289	A5W4	[Not Available]	[Not Available]	BC	Liver	2012
79DF037C-7D37-4E6C-A654-57708A4F87AA	TCGA-BC-A69H	2013-6-18	YES	NO	MALE	173	70	WHITE	NOT HISPANIC OR LATINO	No	No	TUMOR FREE	Alive	NO	[Not Available]	Alcohol consumption	[Not Available]	[Not Available]	NO	NO	NO	Hepatocellular Carcinoma	Segmentectomy, Multiple	G3	R0	7th	T2	NX	M0	Stage II	Micro	A	103900	0	[Not Available]	194000	140000	440000	10.7	9.1	12.0	4.3	3.6	4.8	1.2	0.0	0.4	0.8	0.8	1.3	[Not Available]	None	1	NO	64	-23380	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	[Not Applicable]	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	120	A69H	[Not Available]	[Not Available]	BC	Liver	2013
70AECC90-17F0-4064-8EBB-BE81F9B1D7FD	TCGA-BC-A69I	2013-6-18	YES	NO	MALE	180	95	WHITE	[Not Evaluated]	No	No	TUMOR FREE	Alive	YES	1	No History of Primary Risk Factors	[Not Available]	[Not Available]	NO	NO	NO	Hepatocellular Carcinoma	Segmentectomy, Multiple	G1	R0	7th	T1	N0	M0	Stage I	None	[Unknown]	2	0	10	171000	150000	440000	10.4	9.9	13.0	[Not Available]	[Not Available]	[Not Available]	1.2	0.0	1.2	1.2	0.7	1.3	[Not Available]	None	0	NO	69	-25370	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	[Not Applicable]	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	16	A69I	[Not Available]	[Not Available]	BC	Liver	2013
aeb17d2b-fa8c-4989-bf3a-d2c74b785455	TCGA-DD-A113	2010-12-29	NO	YES	FEMALE	154	56	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	Alive	[Not Available]	[Not Available]	Other	Smoking	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Segmentectomy, Multiple	G3	R0	6th	T2	N0	M0	Stage II	Micro	A	133	0	6	365	150	450	0.9	0.9	1.2	4.3	3.5	5.0	1.0	0.1	0.5	0.8	0.7	1.2	0 - No Fibrosis	None	1	[Not Available]	55	-20188	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	[Not Applicable]	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	1678	A113	[Not Available]	[Not Available]	DD	Liver	2006
02931491-f56b-4233-a079-812e08bc0c59	TCGA-DD-A114	2010-12-29	NO	YES	MALE	173	74	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	No	No	[Not Available]	Dead	NO	[Not Available]	Hepatitis C	[Not Available]	Hepatitis C Virus RNA|HCV Genotype|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Lobectomy	G3	R0	6th	T2	[Not Available]	M0	Stage II	Micro	A	21	0	6	185	150	450	1.0	0.9	1.2	3.5	3.5	5.0	1.0	0.1	2.5	1.2	0.9	1.4	5 - Nodular Formation and Incomplete Cirrhosis	Mild	1	[Not Available]	42	-15410	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	1149	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	[Not Available]	A114	[Not Available]	[Not Available]	DD	Liver	2005
45b566d7-f120-471c-a94a-be7936889f2d	TCGA-DD-A115	2010-12-29	NO	YES	MALE	168	79	WHITE	[Not Available]	No	No	WITH TUMOR	Dead	NO	[Not Available]	Alcohol consumption	Smoking	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Extended Lobectomy	G2	R0	5th	T3	N0	M0	Stage IIIA	None	A	10	0	6	337	150	450	1.0	[Not Available]	[Not Available]	4.1	3.5	5.0	1.0	0.1	0.6	1.1	0.1	1.2	0 - No Fibrosis	None	0	[Not Available]	53	-19697	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	2542	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	[Not Available]	A115	[Not Available]	[Not Available]	DD	Liver	2002
994347ba-3045-4ade-926f-06420fbd906c	TCGA-DD-A116	2010-12-29	NO	YES	MALE	175	73	ASIAN	NOT HISPANIC OR LATINO	No	No	TUMOR FREE	Dead	NO	0	Hepatitis B	[Not Available]	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Segmentectomy, Multiple	G3	R0	5th	T3	N0	M0	Stage IIIA	[Not Available]	A	24	0	6	157	150	450	1.0	[Not Available]	[Not Available]	4.1	3.5	5.0	1.0	0.1	1.1	1.1	0.8	1.4	3,4 - Fibrous Speta	[Not Available]	1	[Not Available]	68	-24934	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	1622	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	[Not Available]	A116	[Not Available]	[Not Available]	DD	Liver	2002
7d914d07-f250-4c7a-8fa2-df14e708936e	TCGA-DD-A118	2010-12-29	NO	YES	FEMALE	169	75	WHITE	NOT HISPANIC OR LATINO	No	No	[Not Available]	Alive	NO	[Not Available]	[Not Available]	[Not Available]	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Lobectomy	G2	R0	6th	T2	N0	M0	Stage II	None	A	85150	0	6	381	150	450	1.0	[Not Available]	[Not Available]	3.4	3.4	4.8	1.0	0.1	0.5	0.9	0.7	1.2	0 - No Fibrosis	None	1	[Not Available]	77	-28406	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	[Not Applicable]	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	693	A118	[Not Available]	[Not Available]	DD	Liver	2003
66c6f413-b7a8-4d7c-9e1d-c4fb257b9e5c	TCGA-DD-A119	2010-12-29	NO	YES	MALE	160	58	ASIAN	NOT HISPANIC OR LATINO	No	No	[Not Available]	Dead	YES	2	Hepatitis B	[Not Available]	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Extended Lobectomy	G3	R2	6th	T3a	N0	M1	Stage IV	Micro	A	1836	0	6	572	150	450	1.0	[Not Available]	[Not Available]	3.9	3.5	5.0	1.0	0.1	1.6	1.3	0.9	1.4	0 - No Fibrosis	None	1	[Not Available]	40	-14613	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	223	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	[Not Available]	A119	[Not Available]	[Not Available]	DD	Liver	2003
609c82fd-eb3a-46d7-8c09-0cde281a50b3	TCGA-DD-A11A	2010-12-29	NO	YES	MALE	156	67	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	No	No	[Not Available]	Alive	NO	[Not Available]	Other	HBcAB total (+), HBsAg (-), HBcIgm Ab (-)	Hepatitis B Surface Antigen|HBV Core Antibody	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Lobectomy	G3	R0	6th	T1	N0	M0	Stage I	None	[Not Available]	223	0	6	513	150	450	1.0	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	1.0	0.1	3.6	1.1	0.9	1.4	0 - No Fibrosis	None	0	[Not Available]	67	-24646	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	[Not Applicable]	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	79	A11A	[Not Available]	[Not Available]	DD	Liver	2004
1b1b1af0-b19b-4086-b1b7-669fa0b88235	TCGA-DD-A11B	2010-12-29	NO	YES	MALE	181	134	WHITE	NOT HISPANIC OR LATINO	No	No	TUMOR FREE	Dead	NO	[Not Available]	Non-Alcoholic Fatty Liver Disease	[Not Available]	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Segmentectomy, Single	G2	RX	6th	T1	N0	M0	Stage I	None	A	15	0	6	90	150	450	10.2	8.4	12.0	3.9	3.5	5.0	1.0	0.1	1.6	1.0	0.9	1.4	6 - Established Cirrhosis	Mild	1	[Not Available]	73	-26857	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	14	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	[Not Available]	A11B	[Not Available]	[Not Available]	DD	Liver	2005
023a1ad1-fb16-437e-9806-5063b47f76bd	TCGA-DD-A11C	2010-12-29	NO	YES	MALE	186	123	WHITE	NOT HISPANIC OR LATINO	No	No	TUMOR FREE	Alive	YES	1	[Not Available]	[Not Available]	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Lobectomy	G3	RX	6th	T1	N0	M0	Stage I	None	A	11	0	6	391	150	450	1.0	[Not Available]	[Not Available]	3.6	3.5	5.0	1.0	0.1	2.3	0.9	0.9	1.4	0 - No Fibrosis	None	1	[Not Available]	69	-25403	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	[Not Applicable]	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	662	A11C	[Not Available]	[Not Available]	DD	Liver	2006
0ef95351-0133-4f34-a59c-90934fb161f8	TCGA-DD-A11D	2010-12-29	NO	YES	FEMALE	163	73	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	Dead	YES	2	Non-Alcoholic Fatty Liver Disease	[Not Available]	[Unknown]	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Lobectomy	G2	R0	6th	T1	N0	M0	Stage I	None	A	8	0	6	249	150	450	0.9	0.9	1.2	4.5	3.5	5.0	1.0	0.1	0.5	1.1	0.6	1.1	6 - Established Cirrhosis	None	1	[Not Available]	57	-21003	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	1560	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	[Not Available]	A11D	[Not Available]	[Not Available]	DD	Liver	2006
8153a862-0790-4a33-80db-ed47fedcd4ef	TCGA-DD-A1E9	2011-5-10	NO	YES	MALE	172	101	WHITE	NOT HISPANIC OR LATINO	No	No	[Not Available]	Dead	YES	4	Alcohol consumption	[Not Available]	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Segmentectomy, Multiple	G2	R0	5th	T1	N0	M0	Stage I	None	A	202	0	6	110	150	450	10.4	8.4	12.0	4.1	3.5	5.0	1.0	0.1	13	0.9	0.8	1.3	6 - Established Cirrhosis	Severe	1	[Not Available]	70	-25808	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	2759	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	[Not Available]	A1E9	[Not Available]	[Not Available]	DD	Liver	2002
8052c374-9435-4588-b970-68565c56dbb7	TCGA-DD-A1EA	2011-5-16	NO	YES	MALE	168	94	ASIAN	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	Alive	YES	1	Hepatitis B	smoking	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody|HBV DNA	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Segmentectomy, Multiple	G2	R0	5th	T2	N0	M0	Stage II	Micro	A	3	0	6	209	150	450	10.2	8.3	10.8	3.3	3.5	5.0	1.0	0.1	0.9	1.2	0.8	1.3	1,2 - Portal Fibrosis	Mild	0	[Not Available]	68	-24925	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	[Not Applicable]	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	2415	A1EA	[Not Available]	[Not Available]	DD	Liver	2002
68015cc7-d3a1-4c90-b8fb-5d14143d9960	TCGA-DD-A1EB	2011-5-9	NO	YES	FEMALE	164	57	[Not Available]	[Not Available]	No	No	WITH TUMOR	Alive	YES	1	Other	smoking	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Lobectomy	G2	R0	5th	T1	N0	M0	Stage I	None	B	7	0	6	204	150	450	8.7	8.4	12.0	3.7	3.5	5.0	1.0	0.1	0.3	1.3	0.6	1.1	0 - No Fibrosis	None	1	[Not Available]	72	-26471	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	[Not Applicable]	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	2017	A1EB	[Not Available]	[Not Available]	DD	Liver	2001
520a709a-87f6-4f3d-b2a2-9192e3b65c5b	TCGA-DD-A1EC	2011-4-6	NO	YES	FEMALE	157	50	WHITE	NOT HISPANIC OR LATINO	No	No	[Not Available]	Alive	NO	[Not Available]	[Not Available]	[Not Available]	[Unknown]	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Segmentectomy, Multiple	G3	R0	6th	T1	N0	M0	Stage I	None	A	2	0	6	556	150	450	11.0	8.4	12.0	3.2	3.5	5.0	1.0	0.1	0.4	0.8	0.7	1.2	0 - No Fibrosis	None	1	[Not Available]	20	-7363	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	[Not Applicable]	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	602	A1EC	[Not Available]	[Not Available]	DD	Liver	2004
0ff6364a-e6f4-47ca-a7e7-14705bf0a8df	TCGA-DD-A1ED	2011-5-16	NO	YES	MALE	168	85	WHITE	NOT HISPANIC OR LATINO	No	No	TUMOR FREE	Alive	NO	[Not Available]	Alcohol consumption	tattoos	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Segmentectomy, Multiple	G1	R0	6th	T1	N0	M0	Stage I	None	A	3	0	6	219	150	450	8.9	8.4	12.0	4.2	3.5	5.0	1.0	0.1	0.8	1.3	0.8	1.3	0 - No Fibrosis	None	1	[Not Available]	68	-25039	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	[Not Applicable]	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	1629	A1ED	[Not Available]	[Not Available]	DD	Liver	2006
654af137-70d9-4ee4-9f69-793e352d30f8	TCGA-DD-A1EE	2011-5-10	NO	YES	MALE	175	77	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	Alive	NO	[Not Available]	Hepatitis C	[Not Available]	Hepatitis C Virus RNA|HCV Genotype|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Segmentectomy, Multiple	G3	R0	6th	T3	N0	M0	Stage IIIA	None	B	3	0	6	208	150	450	14.3	8.4	12.0	2.7	3.5	5.0	1.0	0.1	0.5	1.2	0.8	1.3	6 - Established Cirrhosis	Severe	2	[Not Available]	73	-26858	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	[Not Applicable]	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	204	A1EE	[Not Available]	[Not Available]	DD	Liver	2006
1c1e8987-676f-417b-b3b4-e0321367df55	TCGA-DD-A1EF	2011-5-10	NO	YES	FEMALE	164	81	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	Dead	YES	9	No History of Primary Risk Factors	[Not Available]	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Lobectomy	G3	R0	6th	T1	N0	M0	Stage I	None	B	16211	0	6	337	150	450	8.5	8.4	12.0	4.5	3.5	5.0	1.0	0.1	1.0	0.9	0.6	1.1	3,4 - Fibrous Speta	Mild	2	[Not Available]	57	-21165	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	394	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	[Not Available]	A1EF	[Not Available]	[Not Available]	DD	Liver	2007
6C79F64B-63FE-46F5-BF7B-77208231B0F2	TCGA-DD-A1EG	2013-4-9	NO	YES	MALE	168	82	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	Dead	YES	1	Alcohol consumption|Non-Alcoholic Fatty Liver Disease	[Not Available]	Hepatitis B Surface Antigen	NO	YES	YES	Hepatocellular Carcinoma	Lobectomy	G3	R0	7th	T1	N0	M0	Stage I	None	A	16	0	6	146	150	450	9.1	8.4	12.0	4.2	3.5	5.0	1.0	0.1	0.7	0.6	0.8	1.3	1,2 - Portal Fibrosis	Mild	0	YES	76	-28108	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	1372	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	[Not Available]	A1EG	[Not Available]	[Not Available]	DD	Liver	2007
cab5b264-abab-4bdb-816e-9d2c0ac30629	TCGA-DD-A1EH	2011-5-16	NO	YES	MALE	179	70	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	Alive	YES	1	Hepatitis B	[Not Available]	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody|HBV DNA	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Lobectomy	G3	R0	6th	T3	N0	M0	Stage III	Macro	B	94340	0	6	212	150	450	10.4	9.5	13.8	4.7	3.5	5.0	1.0	0.1	1.0	1.0	0.8	1.3	3,4 - Fibrous Speta	None	1	[Not Available]	23	-8499	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	[Not Applicable]	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	1036	A1EH	[Not Available]	[Not Available]	DD	Liver	2008
3acf7438-fd65-442c-8a30-68b6714537f3	TCGA-DD-A1EI	2011-5-10	NO	YES	MALE	175	69	ASIAN	NOT HISPANIC OR LATINO	No	No	TUMOR FREE	Alive	NO	0	Hepatitis B	cirrhosis	Hepatitis B Surface Antigen|HBV DNA	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Lobectomy	G2	R0	6th	T1	N0	M0	Stage I	None	B	24	0	6	148	150	450	10.9	8.3	10.8	5.1	3.5	5.0	1.0	0.1	0.7	0.9	0.8	1.3	6 - Established Cirrhosis	Mild	2	[Not Available]	46	-17097	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	[Not Applicable]	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	183	A1EI	[Not Available]	[Not Available]	DD	Liver	2008
52292ffc-0902-4d97-b461-20723987a177	TCGA-DD-A1EJ	2011-5-10	NO	YES	FEMALE	154	64	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	Alive	YES	1	No History of Primary Risk Factors	[Not Available]	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Lobectomy	G2	R0	6th	T1	N1	M0	Stage IIIC	None	B	18840	0	6	608	150	450	10.2	8.3	10.8	3.5	3.2	5.0	1.0	0.1	0.7	0.6	0.6	1.1	0 - No Fibrosis	Mild	2	[Not Available]	71	-26009	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	[Not Applicable]	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	887	A1EJ	[Not Available]	[Not Available]	DD	Liver	2008
A5E4412B-0E49-4D86-9CCE-71F440A84048	TCGA-DD-A1EK	2013-4-9	NO	YES	FEMALE	159	97	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	Dead	YES	1	Other	tobacco, birth control bills	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	NO	NO	YES	Hepatocellular Carcinoma	Segmentectomy, Multiple	G2	R0	6th	T4	N0	M1	Stage IVB	None	A	19	0	6	387	150	450	10.3	8.3	10.8	4.3	3.5	5.0	1.0	0.1	0.5	0.7	0.6	1.1	0 - No Fibrosis	Mild	0	YES	64	-23437	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	558	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	[Not Available]	A1EK	[Not Available]	[Not Available]	DD	Liver	2008
2854ffe8-1f77-497a-bf49-11e0189fee35	TCGA-DD-A1EL	2011-5-16	NO	YES	MALE	182	54	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	Dead	NO	[Not Available]	Hepatitis B	[Not Available]	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody|HBV DNA	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Segmentectomy, Multiple	G3	R0	6th	T2	N0	M0	Stage II	None	A	5	0	6	153	150	450	10.8	8.3	10.8	4.4	3.5	5.0	1.0	0.1	0.5	1.0	0.8	1.3	0 - No Fibrosis	Mild	0	[Not Available]	23	-8573	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	415	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	[Not Available]	A1EL	[Not Available]	[Not Available]	DD	Liver	2009
DD056692-4E2A-4E45-A4D0-357AF9754F0E	TCGA-DD-A39V	2012-1-5	NO	YES	MALE	174	79	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	Dead	YES	3	No History of Primary Risk Factors	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Lobectomy	G3	R0	5th	T2	NX	M0	Stage II	None	A	[Not Available]	[Not Available]	[Not Available]	193	150	450	11.4	8.4	12.0	4.0	3.5	5.0	[Not Available]	[Not Available]	[Not Available]	0.9	0.8	1.2	0 - No Fibrosis	None	1	[Not Available]	77	-28254	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	643	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	[Not Available]	A39V	[Not Available]	[Not Available]	DD	Liver	2000
0D0A10B4-7B99-4043-A129-89844F258156	TCGA-DD-A39X	2012-1-5	NO	YES	FEMALE	152	48	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	Dead	YES	2	No History of Primary Risk Factors	[Not Available]	Hepatitis B Surface Antigen|HBV Surface Antibody	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Segmentectomy, Multiple	G2	R0	5th	T1	NX	M0	Stage I	None	A	10	0	6	180	150	450	9.8	8.4	12.0	4.1	3.5	5.0	1.0	0.1	0.5	0.9	0.6	0.9	0 - No Fibrosis	None	1	[Not Available]	78	-28528	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	1694	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	[Not Available]	A39X	[Not Available]	[Not Available]	DD	Liver	1998
BED1D731-E382-4B80-9604-E6DD68D9C0AB	TCGA-DD-A39Y	2012-1-5	NO	YES	MALE	176	85	ASIAN	NOT HISPANIC OR LATINO	No	No	TUMOR FREE	Dead	YES	[Not Available]	No History of Primary Risk Factors	[Not Available]	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Extended Lobectomy	G3	R0	5th	T1	NX	M0	Stage I	None	A	5600	0	6	243	150	450	10.2	8.4	12.0	4.0	3.5	5.0	1.0	0.1	1.1	0.8	1.2	12.0	0 - No Fibrosis	None	2	[Not Available]	67	-24769	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	171	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	[Not Available]	A39Y	[Not Available]	[Not Available]	DD	Liver	2002
AE99D9FD-1735-4217-B4EF-33B377FBD594	TCGA-DD-A3A0	2012-1-5	NO	YES	MALE	178	88	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	Dead	NO	[Not Available]	No History of Primary Risk Factors	[Not Available]	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Segmentectomy, Multiple	G2	R0	5th	T1	NX	M0	Stage I	None	A	1	0	6	138	150	450	13.2	8.4	12.0	3.3	3.5	5.0	1.0	0.1	1.4	2.7	0.8	1.2	0 - No Fibrosis	None	1	[Not Available]	70	-25889	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	785	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	[Not Available]	A3A0	[Not Available]	[Not Available]	DD	Liver	2001
877B9F6B-9B34-40ED-933F-8FEF204EDF21	TCGA-DD-A3A1	2012-1-6	NO	YES	MALE	185	78	[Not Available]	[Not Available]	No	No	TUMOR FREE	Dead	YES	1	No History of Primary Risk Factors	[Not Available]	[Unknown]	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Extended Lobectomy	G2	R0	5th	T3b	N0	M0	Stage IIIA	Macro	A	6	0	6	178	150	450	11.2	8.4	12.0	3.8	3.5	5.0	1.1	0.1	0.8	1.1	0.8	1.2	0 - No Fibrosis	None	0	[Not Available]	65	-24046	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	233	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	[Not Available]	A3A1	[Not Available]	[Not Available]	DD	Liver	2001
AB35C9F9-3040-424D-A89F-DFF3A1365BC6	TCGA-DD-A3A4	2012-1-6	NO	YES	MALE	189	65	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	Dead	YES	2	Other	Tobacco use	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Extended Lobectomy	G3	R0	5th	T3	N0	M0	Stage IIIA	None	B	[Not Available]	[Not Available]	[Not Available]	283	150	450	11.0	8.4	12.0	3.3	3.5	5.0	1.0	0.1	1.0	1.0	0.4	1.2	0 - No Fibrosis	None	0	[Not Available]	37	-13739	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	612	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	[Not Available]	A3A4	[Not Available]	[Not Available]	DD	Liver	1998
C4C4820B-6F4C-4CDD-B233-4D22F5933FD9	TCGA-DD-A3A6	2012-1-6	NO	YES	FEMALE	175	52	WHITE	NOT HISPANIC OR LATINO	No	No	TUMOR FREE	Dead	NO	[Not Available]	No History of Primary Risk Factors	[Not Available]	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Extended Lobectomy	G2	R0	4th	T2	N0	M0	Stage II	Micro	A	[Not Available]	[Not Available]	[Not Available]	4	0	6	9.3	8.4	12.0	4.3	3.5	5.0	1.1	0.1	0.4	1.0	0.6	0.9	0 - No Fibrosis	None	0	[Not Available]	72	-26319	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	3258	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	[Not Available]	A3A6	[Not Available]	[Not Available]	DD	Liver	1997
614C0ECF-6A84-4C86-8706-79BE5BB00991	TCGA-DD-A3A7	2013-4-9	NO	YES	MALE	188	80	[Unknown]	[Unknown]	No	No	WITH TUMOR	Dead	YES	4	Alcohol consumption|Other	tobacco	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	NO	NO	NO	Hepatocellular Carcinoma	Lobectomy	G3	R0	7th	T3b	N0	M0	Stage IIIB	Micro	[Unknown]	120	0	6	562	150	450	10.6	8.4	12.0	[Not Available]	[Not Available]	[Not Available]	1.1	0.1	0.8	1.4	0.8	1.2	0 - No Fibrosis	Mild	1	YES	67	-24599	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	419	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	[Not Available]	A3A7	[Not Available]	[Not Available]	DD	Liver	1998
69D6881B-9E9A-407B-8B02-BAD5FC2455BF	TCGA-DD-A3A8	2012-1-6	NO	YES	MALE	177	99	WHITE	NOT HISPANIC OR LATINO	Yes	No	TUMOR FREE	Dead	YES	3	No History of Primary Risk Factors	[Not Available]	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Lobectomy	G2	R0	5th	T2	N0	M0	Stage II	None	A	4	0	6	251	150	450	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	1.0	0.1	1.0	0.9	0.8	1.2	0 - No Fibrosis	None	1	[Not Available]	75	-27524	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	11	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	[Not Available]	A3A8	[Not Available]	[Not Available]	DD	Liver	2001
457CCA7C-A8B4-414E-A3C0-7FCCF0EE2034	TCGA-DD-A3A9	2012-1-5	NO	YES	FEMALE	168	62	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	Dead	NO	[Not Available]	Other	smoker	[Unknown]	[Not Available]	[Not Available]	[Not Available]	Hepatocellular Carcinoma	Lobectomy	G2	R0	5th	T4	N0	M1	Stage IVB	None	A	19930	0	6	317	150	450	9.3	8.4	12.0	4.0	3.5	5.0	1.0	0.1	0.3	0.9	0.6	0.9	0 - No Fibrosis	None	1	[Not Available]	64	-23526	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	931	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	[Not Available]	A3A9	[Not Available]	[Not Available]	DD	Liver	2001
BEE9D6C8-948F-4B76-97CA-B985064249EF	TCGA-DD-A4NA	2012-12-21	NO	YES	FEMALE	166	93	WHITE	NOT HISPANIC OR LATINO	No	No	TUMOR FREE	Alive	YES	2	No History of Primary Risk Factors	[Not Available]	Hepatitis B Surface Antigen|HBV Surface Antibody	[Unknown]	[Unknown]	[Unknown]	Hepatocellular Carcinoma	Extended Lobectomy	G3	R0	6th	T2	N1	M0	Stage IIIC	[Not Available]	[Unknown]	3	0	6	332	150	450	9.6	8.3	10.8	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	0.8	0.6	1.1	5 - Nodular Formation and Incomplete Cirrhosis	None	0	NO	67	-24603	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	[Not Applicable]	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	1008	A4NA	[Not Available]	[Not Available]	DD	Liver	2009
1983FADE-44F1-41E0-8983-F2CE8D649655	TCGA-DD-A4NB	2012-12-18	NO	YES	MALE	185	69	WHITE	NOT HISPANIC OR LATINO	No	No	TUMOR FREE	Alive	YES	2	No History of Primary Risk Factors	[Not Available]	[Unknown]	NO	NO	NO	Fibrolamellar Carcinoma	Segmentectomy, Multiple	G2	R0	7th	T1	N0	M0	Stage I	None	[Unknown]	3	0	6	296	150	450	13.9	9.5	13.8	[Not Available]	[Not Available]	[Not Available]	1.0	0.1	1.0	0.8	0.8	1.3	[Unknown]	Mild	1	NO	25	-9426	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	[Not Applicable]	[Not Available]	[Not Applicable]	C22.0	8171/3	C22.0	YES	391	A4NB	[Not Available]	[Not Available]	DD	Liver	2011
C0BF9278-9CBB-4361-B4D8-AB172B67E276	TCGA-DD-A4ND	2012-12-18	NO	YES	FEMALE	162	89	WHITE	NOT HISPANIC OR LATINO	Yes	No	WITH TUMOR	Alive	YES	3	No History of Primary Risk Factors	[Not Available]	[Unknown]	NO	NO	NO	Hepatocellular Carcinoma	Lobectomy	G3	R0	6th	T1	N0	M0	Stage I	None	A	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	8.8	8.4	12	3.9	3.5	5	1	0.1	0.5	0.7	0.6	1.1	0 - No Fibrosis	None	1	YES	56	-20782	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	[Not Applicable]	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	2141	A4ND	[Not Available]	[Not Available]	DD	Liver	2007
BCE25281-502E-4599-9679-32DC8462FFB1	TCGA-DD-A4NE	2012-12-21	NO	YES	FEMALE	170	79	WHITE	HISPANIC OR LATINO	No	No	WITH TUMOR	Dead	YES	3	No History of Primary Risk Factors	[Not Available]	Hepatitis C Virus RNA|Hepatitis B Surface Antigen|HBV Core Antibody	NO	NO	NO	Hepatocellular Carcinoma	Extended Lobectomy	G3	R0	7th	T3a	N0	M0	Stage IIIA	None	A	28	0	6	348	150	450	10.2	8.3	10.8	4.2	3.5	5.0	1.0	0.1	0.9	0.8	0.6	1.0	0 - No Fibrosis	None	0	YES	75	-27549	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	660	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	[Not Available]	A4NE	[Not Available]	[Not Available]	DD	Liver	2011
1043BC90-72C9-48C9-AE24-F617D0485E78	TCGA-DD-A4NF	2013-1-29	NO	YES	MALE	173	86	WHITE	NOT HISPANIC OR LATINO	No	No	TUMOR FREE	Alive	NO	[Not Available]	Hepatitis C	[Not Available]	Hepatitis C Virus RNA|HCV Genotype|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	NO	NO	NO	Hepatocellular Carcinoma	Segmentectomy, Single	G2	R0	7th	T1	N0	M0	Stage I	None	A	6	0	6	97	150	450	12.7	9.5	13.8	4	3.5	5.0	1.0	0.1	0.5	0.9	0.8	1.3	6 - Established Cirrhosis	Mild	0	NO	72	-26330	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	[Not Applicable]	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	428	A4NF	[Not Available]	[Not Available]	DD	Liver	2011
89791F8F-DC06-4A04-B166-AFBFD6CF53DE	TCGA-DD-A4NG	2013-1-29	NO	YES	MALE	164	94	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	Alive	YES	1	Alcohol consumption	[Not Available]	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	NO	NO	NO	Hepatocellular Carcinoma	Segmentectomy, Multiple	G2	R0	7th	T3a	NX	M0	Stage IIIA	Micro	A	3	0	6	220	150	450	10.6	8.3	10.8	4.5	3.5	5.0	1.0	0.1	0.5	0.9	0.8	1.3	[Unknown]	None	1	YES	77	-28234	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	[Not Applicable]	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	445	A4NG	[Not Available]	[Not Available]	DD	Liver	2011
4012EA90-5768-4ACC-AF3A-BA954F493DB4	TCGA-DD-A4NH	2013-1-29	NO	YES	FEMALE	157	81	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	Alive	YES	1	Alcohol consumption	[Not Available]	Hepatitis B Surface Antigen	NO	NO	NO	Hepatocellular Carcinoma	Extended Lobectomy	G3	R0	7th	T3b	N0	M0	Stage IIIB	Macro	A	92889	0	6	226	150	450	11.8	9.5	13.8	4.0	3.5	5.0	1.0	0.1	0.6	0.8	0.6	1.1	1,2 - Portal Fibrosis	None	0	YES	65	-23865	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	[Not Applicable]	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	433	A4NH	[Not Available]	[Not Available]	DD	Liver	2011
518AA9CC-71CF-4734-9D55-B435DA99D300	TCGA-DD-A4NI	2013-1-29	NO	YES	MALE	172	99	WHITE	NOT HISPANIC OR LATINO	Yes	No	TUMOR FREE	Alive	YES	6	Alcohol consumption|Non-Alcoholic Fatty Liver Disease	tobacco	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	NO	NO	NO	Hepatocellular Carcinoma	Lobectomy	G2	R0	7th	T2	NX	M0	Stage II	None	A	6	0	6	187	150	450	12.4	9.5	13.8	4.4	3.5	5.0	1.0	0.1	0.6	1.1	0.8	1.3	0 - No Fibrosis	[Unknown]	0	NO	67	-24516	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	[Not Applicable]	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	328	A4NI	[Not Available]	[Not Available]	DD	Liver	2011
815DFFB0-0C22-4E05-868C-26E6C553980A	TCGA-DD-A4NJ	2013-2-5	NO	YES	FEMALE	164	88	WHITE	NOT HISPANIC OR LATINO	No	No	TUMOR FREE	Alive	YES	1	Non-Alcoholic Fatty Liver Disease	[Not Available]	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	NO	NO	NO	Hepatocellular Carcinoma	Lobectomy	G2	R0	7th	T2	N0	M0	Stage II	None	A	5	0	6	303	150	450	11.5	9.5	13.8	4.7	3.5	5.0	1.0	0.1	0.4	0.7	0.6	1.1	1,2 - Portal Fibrosis	Mild	0	NO	54	-19964	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	[Not Applicable]	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	458	A4NJ	[Not Available]	[Not Available]	DD	Liver	2011
5B8D04B2-EF40-4216-A3BB-42520EFBE863	TCGA-DD-A4NK	2013-2-5	NO	YES	FEMALE	[Not Available]	84	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	Dead	YES	3	No History of Primary Risk Factors	[Not Available]	Hepatitis B Surface Antigen	NO	NO	YES	Hepatocellular Carcinoma	Lobectomy	G2	R0	6th	T3	N0	M0	Stage IIIA	None	A	3	0	6	372	150	450	8.7	8.4	12.0	4.1	3.5	5.0	1.0	0.1	0.5	1.1	0.7	1.2	0 - No Fibrosis	None	0	YES	80	-29244	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	1210	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	[Not Available]	A4NK	[Not Available]	[Not Available]	DD	Liver	2004
E0067280-2722-46F2-A5A8-352C77B47E38	TCGA-DD-A4NL	2013-2-5	NO	YES	MALE	173	113	WHITE	NOT HISPANIC OR LATINO	No	No	TUMOR FREE	Alive	NO	[Not Available]	Alcohol consumption|Other	Tobacco use	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	NO	NO	NO	Hepatocellular Carcinoma	Segmentectomy, Single	G1	R0	6th	T1	N0	M0	Stage I	None	[Unknown]	2	0	6	266	150	450	[Not Available]	[Not Available]	[Not Available]	4.4	3.5	5.0	1.0	0.1	0.3	1.0	0.8	1.3	0 - No Fibrosis	None	1	NO	46	-16874	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	[Not Applicable]	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	1711	A4NL	[Not Available]	[Not Available]	DD	Liver	2007
B96B7620-5506-4DEF-AFF2-5E888EAF3EA5	TCGA-DD-A4NN	2013-2-5	NO	YES	FEMALE	163	59	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	Dead	YES	1	No History of Primary Risk Factors	[Not Available]	[Unknown]	NO	NO	NO	Hepatocellular Carcinoma	Segmentectomy, Multiple	G3	R0	6th	T1	N0	M0	Stage I	None	A	4223	0	6	307	150	450	8.8	8.0	12.0	4.3	3.5	5.0	1.0	0.1	0.5	0.9	0.7	1.2	0 - No Fibrosis	[Unknown]	0	YES	56	-20548	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	899	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	[Not Available]	A4NN	[Not Available]	[Not Available]	DD	Liver	2004
75F78C38-6854-4390-AD11-789B4E549D63	TCGA-DD-A4NO	2013-2-5	NO	YES	MALE	176	109	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	Alive	NO	[Not Available]	Hepatitis C|Other	Tobacco use	Hepatitis C Virus RNA|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	NO	NO	NO	Hepatocellular Carcinoma	Segmentectomy, Multiple	G1	R0	6th	T1	N0	M0	Stage I	None	A	3	0	6	201	150	450	9.9	8.4	12.0	4.5	3.5	5.0	1.0	0.1	0.4	1.6	0.8	1.3	0 - No Fibrosis	Mild	0	YES	65	-24090	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	[Not Applicable]	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	1869	A4NO	[Not Available]	[Not Available]	DD	Liver	2007
001887AA-36D0-463F-8BCA-DEC7043B4F2E	TCGA-DD-A4NP	2013-2-5	NO	YES	MALE	177	79	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	Alive	NO	[Not Available]	No History of Primary Risk Factors	[Not Available]	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	NO	NO	NO	Hepatocellular Carcinoma	Lobectomy	G3	R0	6th	T1	N0	M0	Stage I	None	B	2	0	6	348	150	450	8.9	8.4	12.0	2.4	3.5	5.0	1.0	0.1	0.7	1.9	0.9	1.4	0 - No Fibrosis	None	0	YES	32	-11838	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	[Not Applicable]	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	2849	A4NP	[Not Available]	[Not Available]	DD	Liver	2005
C05720FE-19C1-4CFF-819B-6806B26FC312	TCGA-DD-A4NQ	2013-2-11	NO	YES	MALE	159	75	WHITE	HISPANIC OR LATINO	No	No	WITH TUMOR	Dead	YES	1	Hepatitis B|Other	tobacco	Hepatitis C Virus RNA|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	NO	NO	NO	Hepatocellular Carcinoma	Segmentectomy, Multiple	G3	R0	6th	T2	N0	M0	Stage II	Macro	A	141	0	6	283	150	450	10.1	8.4	12.0	4.4	3.5	5.0	1.0	0.1	0.7	0.8	0.8	1.3	[Unknown]	Mild	0	YES	60	-22111	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	373	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	[Not Available]	A4NQ	[Not Available]	[Not Available]	DD	Liver	2007
52A7F734-DA07-49C5-861D-C70DA37FF959	TCGA-DD-A4NR	2013-2-11	NO	YES	FEMALE	64	54	WHITE	NOT HISPANIC OR LATINO	No	No	[Unknown]	Dead	YES	1	Other	primary biliary cirrhosis	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	NO	NO	NO	Hepatocellular Carcinoma	Segmentectomy, Single	G3	R0	6th	T1	N0	M0	Stage I	None	A	40250	0	6	239	150	450	9.3	8.4	12.0	3.1	3.5	5.0	1.0	0.1	0.8	1.0	0.7	1.2	6 - Established Cirrhosis	[Unknown]	0	NO	85	-31386	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	9	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	[Not Available]	A4NR	[Not Available]	[Not Available]	DD	Liver	2005
A6A3F07C-CED4-451B-B2E5-C93E4ED622C1	TCGA-DD-A4NS	2013-2-11	NO	YES	FEMALE	167	58	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	Dead	YES	2	Alcohol consumption	[Not Available]	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	NO	NO	NO	Hepatocellular Carcinoma	Lobectomy	G2	R0	6th	T1	N0	M0	Stage I	None	[Unknown]	2	0	6	270	150	450	8.8	8.4	12.0	[Not Available]	[Not Available]	[Not Available]	1.0	0.1	0.9	1.1	0.7	1.2	0 - No Fibrosis	None	0	YES	61	-22638	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	2456	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	[Not Available]	A4NS	[Not Available]	[Not Available]	DD	Liver	2005
8E5CE60B-2EDA-482D-B109-210DF1321AFF	TCGA-DD-A4NV	2013-2-11	NO	YES	MALE	179	129	WHITE	NOT HISPANIC OR LATINO	No	No	TUMOR FREE	Alive	YES	1	Non-Alcoholic Fatty Liver Disease|Other	morbid obesity, tobacco use	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	NO	NO	NO	Hepatocellular Carcinoma	Segmentectomy, Multiple	G1	R0	6th	T3	N0	M0	Stage IIIA	None	A	3	0	6	240	150	450	9.0	8.4	12.0	3.9	3.5	5.0	1.0	0.1	0.5	0.8	0.8	1.3	0 - No Fibrosis	None	1	NO	61	-22438	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Applicable]	0	[Not Applicable]	[Not Available]	[Not Applicable]	C22.0	8170/3	C22.0	YES	2018	A4NV	[Not Available]	[Not Available]	DD	Liver	2007
